Masahiko Morioka1,2, Kuniki Kato1, Kazuo Umezawa3. 1. Department of Applied Chemistry, Faculty of Science and Technology, Keio University, Yokohama, Japan. 2. R&D, Product and Service Development, CXS Corporation, Yokohama, Japan. 3. Department of Molecular Target Medicine, Aichi Medical University School of Medicine, Aichi, Japan.
Authors: H Umezawa; S Kondo; H Iinuma; S Kunimoto; Y Ikeda; H Iwasawa; D Ikeda; T Takeuchi Journal: J Antibiot (Tokyo) Date: 1981-12 Impact factor: 2.649
Authors: T Takeuchi; H Iinuma; S Kunimoto; T Masuda; M Ishizuka; M Takeuchi; M Hamada; H Naganawa; S Kondo; H Umezawa Journal: J Antibiot (Tokyo) Date: 1981-12 Impact factor: 2.649
Authors: S G Nadler; D D Dischino; A R Malacko; J S Cleaveland; S M Fujihara; H Marquardt Journal: Biochem Biophys Res Commun Date: 1998-12-09 Impact factor: 3.575